David Piacquad's Net Worth

$23.5 Million

Estimate Recalculated Nov 7, 2024 12:00PM EST

Who is David Piacquad?

David Piacquad has an estimated net worth of $23.5 Million. This is based on reported shares across multiple companies, which include AMGEN INC, and Neumora Therapeutics, Inc..

SEC CIK

David Piacquad's CIK is 0001602343

Past Insider Trading and Trends

2018 was David Piacquad's most active year for acquiring shares with 5 total transactions. David Piacquad's most active month to acquire stocks was the month of April. 2018 was David Piacquad's most active year for disposing of shares, totalling 8 transactions. David Piacquad's most active month to dispose stocks was the month of March. 2019 saw David Piacquad paying a total of $898,856.15 for 28,759 shares, this is the most they've acquired in one year. In 2020 David Piacquad cashed out on 11,230 shares for a total of $2,534,551.91, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMGEN INC (AMGN) Snapshot price: $320.56

SVP, Business Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.79%
350
$239.64
-$86,030.76
44.79K
Apr 30 - May 3
Form 4
-0.29%
-128.00
$255.52
-$32,706.56
44.44K
Apr 27
Form 4
-2.18%
-991.00
$244.42
-$242,220.22
44.56K
Mar 19
Form 4
+6.18%
2.65K
—
—
45.5K
Mar 2
Form 4
+3.06%
1.27K
—
—
42.77K
May 5
Form 4
-0.62%
-259.00
$234.89
-$60,837.34
41.5K
May 1 - May 3
Form 4
-0.28%
-116.00
$236.28
-$27,408.48
41.76K
Apr 27
Form 4
-3.66%
-1.59K
$198.76
-$316,227.16
41.88K
Mar 20
Form 4
+9.35%
3.71K
—
—
43.41K
Mar 3
Form 4
-18.92%
-9.26K
$229.93
-$2,130,078.93
39.7K
Feb 6
Form 4
-9.77%
-5.30K
$196.18
-$1,039,750.75
48.96K
Dec 13
Form 4
+1.85%
879
$190.43
-$194,458.85
48.49K
Nov 20
Form 4
+3.28%
1.51K
$176.50
-$32,123.00
47.55K
May 3
Form 4
-0.37%
-171.00
$179.32
-$30,664.27
46.05K
May 1
Form 4
-3.16%
-1.51K
$191.89
-$289,562.01
46.22K
Mar 22
Form 4
+8.35%
3.68K
—
—
47.67K
Mar 6
Form 4
-0.37%
-162.00
$192.11
-$31,121.82
44K
Jan 30
Form 4
+6.19%
2.39K
$128.53
-$476,053.33
41.02K
Nov 30
Form 4
+14.06%
5.14K
$112.74
-$863,142.20
41.71K
May 11
Form 4
-0.48%
-178.00
$169.43
-$30,158.54
36.57K
May 3
Form 4
+2.67%
957
—
—
36.74K
Apr 27
Form 4
-0.60%
-217.00
$171.94
-$37,310.98
35.79K
Apr 25
Form 4
-4.05%
-1.52K
$176.08
-$267,465.52
36K
Mar 23
Form 4
+12.05%
4.03K
—
—
37.47K
Mar 7
Form 4
-0.46%
-153.00
$198.00
-$30,294.00
33.44K
Jan 30
Form 4
+3.02%
984
—
—
33.53K
May 1
Form 4
-8.43%
-3.00K
$164.59
-$493,435.20
32.55K
Apr 25 - Apr 26
Form 4
-6.64%
-2.53K
$166.04
-$419,749.12
35.55K
Mar 24
Form 4
+17.42%
5.63K
—
—
37.99K
Mar 7
Form 4
-0.49%
-160.00
$157.16
-$25,145.60
32.35K
Jan 30
Form 4
+3.26%
1.02K
—
—
32.36K
May 3
Form 4
-0.70%
-443.00
$163.16
-$72,236.49
62.97K
Apr 26 - Apr 27
Form 4
-0.66%
-210.00
$163.19
-$34,269.90
31.79K
Apr 25
Form 4
-6.72%
-2.31K
$149.24
-$344,296.68
32K
Mar 25
Form 4
+18.35%
5.3K
—
—
34.21K
Mar 2
Form 4
-10.15%
-3.25K
$167.91
-$546,043.32
28.78K
Apr 25 - Apr 27
Form 4
-12.08%
-4.40K
$160.55
-$706,741.10
32.04K
Mar 27
Form 4
+35.21%
9.46K
—
—
36.32K
Mar 4
Form 4
+4.07%
1.05K
—
—
26.86K
Jan 30
Form 4
-7.07%
-1.96K
—
—
25.71K
Aug 3
Form 4
+2.13%
577
$112.67
-$66,359.69
27.6K
Apr 25 - Apr 27
Form 3
—
0
—
—
0
No matching records found

Neumora Therapeutics, Inc. (NMRA) Snapshot price: $10.46

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
20.1K
—
—
20.1K
Jun 13
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found